Fresenius Medical Care narrowed its operating profit margin target for this year after its fourth-quarter profit slumped. The ...

Fresenius Medical Care’s transformation plan has become evident in a 2024 earnings release as it continues to streamline its ...

FMS' fourth-quarter results showcase a strong segmental performance along with providing full year 2025 outlook for revenue ...

Fresenius Medical Care FMEG.DE, the world's largest dialysis specialist, reported fourth quarter results slightly above ...

Quest Diagnostics will take over the kidney-focused lab testing portfolio of the dialysis giant Fresenius Medical ...

By Rafal Wojciech Nowak and Tristan Veyet (Reuters) -German healthcare group Fresenius reported fourth-quarter earnings above ...

JPMorgan raised the firm’s price target on Fresenius Medical (FMS) to EUR 41.50 from EUR 37.30 and keeps an Underweight rating on the ...

Truist Financial analyst David S Macdonald maintained a Hold rating on Fresenius Medical Care (FMS – Research Report) today. The company’s ...

Fresenius Medical Care plans to sell select assets of Spectra Laboratories to Quest Diagnostics as it exits non-core markets.

Fresenius Medical Care announced today that it agreed to sell select assets of its laboratory testing services to Quest ...

The acquisition will add dialysis-related water testing to Quest’s portfolio and position the company to perform the tests ...

The segment’s EBIT margin expanded to 15.8%, with a structural target raised to 16-18%. Helios saw 6% revenue growth, with ...